TUM Venture Labs

TUM Venture Labs is a joint initiative between the Technical University of Munich and UnternehmerTUM, operating as a domain-specific incubator structure that supports deep tech and healthcare AI founders emerging from the TUM research and engineering ecosystem. The structure is unusual in that it organizes its support by vertical, with dedicated labs for healthcare, AI, robotics, and other domains rather than running a single horizontal program. Healthcare focus areas include AI/ML applications and biotech.

The thesis assumes that the best support for early-stage technical founders is domain-specific rather than generalist, and that the depth of expertise required to commercialize healthcare AI or biotech is meaningfully different from what is required to commercialize, say, robotics or industrial technology. The Venture Labs structure organizes the support accordingly, with each lab staffed by domain operators, researchers, and corporate partners relevant to that vertical. Healthcare investments under this model are typically deeply technical, often spinning out of TUM research groups or affiliated medical centers, and tend to have a strong scientific or engineering foundation.

The initiative provides checks generally below $250k at the pre-seed and seed stages, with the capital functioning as part of a broader package that includes lab access, technical mentorship, and corporate partnership facilitation. Geographically, the focus is Munich and the broader Bavarian and German deep tech corridor, with particular density in companies with TUM connections. The program structure means founders may engage with the labs for an extended period before any capital decision is made, which provides time for both sides to develop conviction and for the company to mature.

The team operates within the broader TUM and UnternehmerTUM institutional context, which provides access to research labs, technical advisory benches, an extensive alumni network, and corporate partners across the German Mittelstand and DAX-listed companies. For healthcare AI and biotech founders, the institutional access is often the most distinctive value, since it provides early commercial signal and technical validation in ways that are difficult to replicate independently.

In working with companies, TUM Venture Labs is most useful for technical advisory, research collaboration, corporate partnership development, and bridging founders into the broader German and European venture ecosystem. The labs have connections into seed and Series A leads in Munich, Berlin, Paris, Zurich, London, and the US that can lead subsequent rounds when companies graduate. For healthcare founders, the fit is strongest for those with research-driven companies emerging from the TUM ecosystem, particularly where the technology requires the kind of corporate partnership access that German Mittelstand connections can provide. The fit is weaker for purely commercial digital health businesses without a research dimension. Founders considering TUM Venture Labs should plan to engage with the program structure substantively and treat the initial check as one component of a broader institutional relationship.